284 related articles for article (PubMed ID: 29426963)
1. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
3. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
5. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
6. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
[TBL] [Abstract][Full Text] [Related]
7. PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics.
Bychkov A; Vutrapongwatana U; Tepmongkol S; Keelawat S
Sci Rep; 2017 Jul; 7(1):5202. PubMed ID: 28701709
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
[TBL] [Abstract][Full Text] [Related]
9. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases.
Manson QF; Schrijver WAME; Ter Hoeve ND; Moelans CB; van Diest PJ
Clin Exp Metastasis; 2019 Feb; 36(1):29-37. PubMed ID: 30547271
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients.
Abdel-Hadi M; Ismail Y; Younis L
Pathol Res Pract; 2014 Nov; 210(11):759-63. PubMed ID: 24951241
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.
Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G
Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790
[TBL] [Abstract][Full Text] [Related]
13. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
[TBL] [Abstract][Full Text] [Related]
14. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
[TBL] [Abstract][Full Text] [Related]
15. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
16. The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers.
Bradbury R; Jiang WG; Cui YX
Biomark Med; 2015; 9(12):1353-70. PubMed ID: 26581688
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific membrane antigen expression in melanoma metastases.
Snow H; Hazell S; Francis N; Mohammed K; O'Neill S; Davies E; Mansfield D; Messiou C; Hujairi N; Nicol D; Harrington K; Smith M
J Cutan Pathol; 2020 Dec; 47(12):1115-1122. PubMed ID: 32529651
[TBL] [Abstract][Full Text] [Related]
18. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.
Wernicke AG; Edgar MA; Lavi E; Liu H; Salerno P; Bander NH; Gutin PH
Arch Pathol Lab Med; 2011 Nov; 135(11):1486-9. PubMed ID: 22032578
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]